KeypointsThis is the First review describing the treatment outcomes of surgery and radiotherapy stratified per Fisch class.For Fisch class A and B tumors surgery is a viable treatment option.For Fisch class c and D tumors radiotherapy results show lower complication rates and similar or better local control rates when compared to the surgical group.Management of jugulotympanic paraganglioma is complex and requires an individualized approach by an experienced team.INTRODUCTIONParagangliomas of the head and neck (HNPs) are rare, comprising about 0.6% of head and neck tumours and 0.03% of all tumours. Thirty per cent of head and neck paragangliomas are jugulotympanic tumours. Jugulotympanic paragangliomas (JTPGL) are slow growing neuro‐endocrine tumours that are benign in almost all cases. Despite the benign nature, symptomatology can be considerable and is mainly caused by growth towards delicate surrounding structures such as cranial nerves (CNs) and large vessels. However, their indolent growth pattern makes it difficult to predict if and when these tumours will become clinically apparent; some tumours cause CN damage or invade the intracranial space, while others show spontaneous regression.It is due to the rarity of paragangliomas and their variable yet potentially debilitating clinical presentation that the management of these tumours remains a matter
Clinical Otolaryngology – Wiley
Published: Jan 1, 2018
Keywords: ; ; ; ;
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera